As we walk through a period of uncertainty, it becomes essential to obtain clear, prompt, and evidence-based indications to guide surgeons and protect OR staff. The SARS-CoV-2 pandemic profoundly modified the patients' case load of most surgical units, affecting both the volume and the quality of care: different behaviors have been suggested to regulate surgical and endoscopic activity during the emergency \[[@CR1]--[@CR6]\] and a significant concern has been raised about the possibility of contagion from patients affected by COVID-19 infection during interventional procedures. It is known that surgical smoke and aerosol generated during a surgical procedure can contain viruses, which in some circumstances has led to infection \[[@CR7]--[@CR9]\]; however, no data have demonstrated the presence of SARS-CoV-2 in the smoke generated during a surgical procedure yet. Moreover, SARS-CoV-2 non-respiratory transmission is still under investigation. Fecal-oral transmission has also been suggested, while viral clearance modality and its timing are not entirely understood \[[@CR10]--[@CR15]\]. Additional concerns were raised about the risk of infection associated with the use of laparoscopy. It has therefore been suggested to reduce the working pressure during abdominal laparoscopy to a minimum and some have also questioned if laparoscopy should be used at all during the pandemics. National guidelines have indeed advised to consider alternative treatments, whenever possible, underlying the suspect of an increased risk of contamination for laparoscopic procedures due to the aerosol diffusion in the OR environment.

Protection of any care-giver and of the surgical team is and must remain a priority. That involves comprehensive measures aimed to prevent established as well as hypothetical risk \[[@CR16]\]. Nonetheless we should in parallel pay our attention to assess the size of the risk, recognize precise modality of viral spread, and study patterns of viral excretion in order to eventually provide our patients the same standard of quality surgery as before. Our practice must be driven by indications which, in turn, should be based on facts. Sampling peritoneal fluid during an open or a laparoscopic procedure is a relatively simple maneuver. However, that not necessarily reflects the size of the risk associated with laparoscopy, due to the related aerosol formation and of its possible diffusion in the OR environment. The possibility to sample the intraperitoneal gas would provide useful information to better understand the pattern of diffusion of COVID-19 and whether the virus is present in the peritoneal cavity and in the pneumoperitoneum of infected patients.

In this report, we describe a simple and easily reproducible method to sample fluid material obtained from the pneumoperitoneum during a laparoscopic procedure. Using commonly procurable, low-cost materials, it is possible to create hydrosol from outflowing gas and smoke, without increasing any chance of contamination for the OR team, nor increasing the duration of the procedure.

Taking forward the already described use of a ventilation machine filter \[[@CR16]\], to limit the potential contamination risk of a laparoscopic procedure, we here suggest adding an intermediate cooling circuit to induce gas condensation and precipitation. The liquid obtained is considered as a good approximation of aerosol produced during a procedure and it can be collected for laboratory tests, such as RT-PCR and viral cultures \[[@CR17], [@CR18]\].

Needed materials and instructions for assembling are indicated in Fig. [1](#Fig1){ref-type="fig"}. The 150-cm IV tube must be pasted inside the container (cyanoacrylate or glue gun), forming a descending serpentine: this will facilitate the dropping of the hydrosol. The flow resistance offered by the circuit and the filter itself is, in our experience, adequate to maintain a proper pneumoperitoneum pressure (10--12 mmHg) even when the circuit is open, and it allows gas transit. From a one hour and a half long procedure, we obtained, with the almost constant filtered flow, 4--5 ml of hydrosol. We suggest using sterile technique to connect the 3-way stopcock with 50-cm IV tube to the trocar, so to avoid contamination of the surgical field. After the procedure, the circuit should be closed at the ends and the hydrosol collected with maximal attention. The system is for single use only and it should be discarded according to hospital indications.Fig. 1Material and assembled circuit: **A** 3-Way stopcock with 50-cm tube (sterile); **B** Universal connector; **C** Mechanical filter connected to the end of 8.0-mm OT-tube; **D** IV tube 150 cm; **E** 3-Way stopcock; **F** Y connector; **G** Histology specimen container 500 ml (filled with ice)

The battle against the SARS-Cov-2 pandemic is still ongoing. In the absence of vaccines or effective drug treatments, it cannot be forecast how long the healthcare system will need to cope with it in managing inpatient and outpatient services \[[@CR19]\]. Our duty, as healthcare professionals, is to protect ourselves and our co-workers most rationally and effectively possible \[[@CR20]\]. Such an aim can be obtained by increasing and sharing the available knowledge about the disease. At the same time, it is our responsibility to guarantee the highest standards of care, among all minimal invasiveness. We do hope that this method will help to obtain new data, so to quantify exposure risks, improve protection strategies, and explore known issues about the physiopathology of SARS-Cov-2.
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